Phase III trial of pramlintide + metreleptin combination therapy in patients with obesity.
Phase of Trial: Phase III
Latest Information Update: 04 Aug 2011
At a glance
- Drugs Metreleptin (Primary) ; Pramlintide (Primary)
- Indications Obesity
- Focus Registrational; Therapeutic Use
- Sponsors Amylin Pharmaceuticals; Takeda
- 04 Aug 2011 Status changed from planning to discontinued.
- 24 Feb 2010 New trial record